|
參考文獻
1. Niederreither K, Subbarayan V, Dolle P, Chambon P. Embryonic retinoic
acid synthesis is essential for early mouse post-implantation development.
Nature Genet; 21: 444–448 (1999).
2. Massaro GD. Retinoic acid receptor-β: an endogenous inhibitor of the
perinatal formation of pulmonary alveoli. Physiol. Genomics; 4: 51–57
(2000).
3. Dupe V. Essential roles of retinoic acid signaling in interdigital
apoptosis and control of BMP-7 expression in mouse autopods. Dev. Biol;
208: 30–43 (1999).
4. Altucci L. Retinoic acid-induced apoptosis in leukemia cells is
mediated by paracrine action of tumorselective death ligand trail. Nature
Med; 7: 680–686 (2001).
5. Altucci L, Gronemeyer H. The promise of retinoids to fight against cancer. Nature Reviews Cancer; 1: 181-193 (2001).
6. Evans RM. The steroid and thyroid hormone receptor superfamily. Science; 240(4854): 889-895 (1988).
7. McKenna NJ, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol; 69(1-6): 3-12 (1999).
8. McKenna NJ, Lanz RB, O'Malley BW. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev; 3: 321-344 (1999).
9. Stunnenberg HG. Mechanisms of transactivation by retinoic acid receptors.
Bioessays; 15(5): 309-15 (1993).
10. Weatherman RV, Fletterick RJ, Scanlan TS. Nuclear-receptor ligands and ligand-binding domains. Annu Rev Biochem; 68: 559-581 (1999).
11. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J; 10(9): 940-954 (1996).
12. Umesono K, Murakami KK, Thompson CC, Evans RM. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell; 65(7): 1255-1266 (1991).
13. Dong Z, Birrer MJ, Watts RG, Matrisian LM, Colburn NH. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl Acad. Sci. USA ; 91: 609–613 (1994).
14. Fanjul A, et al. A new class of retinoids with selective inhibition of AP-1
inhibits proliferation. Nature; 372: 107–111 (1994).
15. Shyu RY, Jiang SY, Huang SL, Chang TC, Wu KL, Roffler SR, Yeh MY. Growth regulation by all-trans-retinoic acid and retinoic acid receptor messenger ribonucleic acids expression in gastric cancer cells. Eur J Cancer; 31A(2): 237-243 (1995).
16. Huang SL, Shyu RY, Yeh MY, Jiang SY. Cloning and characterization of a novel retinoid-inducible gene 1(RIG-1) deriving from human gastric cancer cells. Mol Cell Endocrinol; 159(1-2): 15-24 (2000).
17. DiSepio D, Ghosn C, Richard L, Eckert, Deucher A, Robinson N, Duvic M, Roshantha AS, Chandraratna, Nagpal S. Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. PNAS; 95: 14811-14815 (1998).
18. Huang SL, Shyu RY, Yeh MY, Jiang SY. The retinoid-inducible gene I: effect on apoptosis and mitogen-activated kinase signal pathways. Anticancer Res; 22(2A): 799-804 (2002).
19. Jiang SY, Wu MS, Chen LM, Hung MW, Lin HE, Chang GG, Chang TC. Identification and characterization of the retinoic acid response elements in the human RIG-1 gene promoter. Biochem Biophys Res Commun; 331(2): 630-639 (2005).
20. Xu C, Li YT, Kong AN. Induction of Phase I, II and III Drug Metabolism/Transport by Xenobiotics. Arch Pharm Res; 28(3): 249-268 (2005).
21. Xie W, Ronald ME. Orphan Nuclear Receptors: The Exotics of Xenobiotics. J Biol Chem; 276(41): 7739–37742 (2001).
22. Crews ST, Fan CM. Remembrance of things PAS: regulation of development by bHLH-PAS proteins. Curr Opin Genet Dev; 5: 580-587 (1999).
23. Carver LA, LaPres JJ, Jain S, Dunham EE, Bradfield CA. Characterization of the Ah receptor-associated protein, ARA9. J Biol Chem; 273(50): 33580-33587 (1998).
24. Kazlauskas A, Poellinger L, Pongratz I. The immunophilin-like protein XAP2 regulates ubiquitination and subcellular localization of the dioxin receptor. J Biol Chem; 275(52): 41317-41324 (2000).
25. Reyes H, Reisz-Porszasz S, Hankinson O. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science; 256: 1193-1195 (1992).
26. Watson AJ, Hankinson O. Dioxin- and Ah receptor-dependent protein binding to xenobiotic responsive elements and G-rich DNA studied by in vivo footprinting. J Biol Chem; 267(10): 6874-6878 (1992).
27. Fujii-Kuriyama Y, Imataka H, Sogawa K, Yasumoto K, Kikuchi Y. Regulation of CYP1A1 expression. FASEB J; 6(2): 706-710 (1992).
28. Murphy KA, Caren M, Dorn R, Lori A. Interaction between the Aryl
Hydrocarbon Receptor and Retinoic Acid Pathways Increases Matrix
Metalloproteinase-1 Expression in Keratinocytes. J Biol Chem; 279(24):
25284–25293 (2004).
29. Grange T, Roux J, Rigaud G, Pictet R. Cell-type specific activity of two glucocorticoid responsive units of rat tyrosine aminotransferase gene is associated with multiple binding sites for C/EBP and a novel liverspecific
nuclear factor. Nucleic Acids Research; 19(1): 131-139 (1990)
30. Rigaud G, Roux J, Pictet R, Grange T. In Vivo Footprinting of Rat TAT Gene: Dynamic Interplay between the Glucocorticoid Receptor and a Liver-Specific Factor. Cell; 67: 977-986 (1991)
31. Sen E, Jennifer L, Bromberg-White, Meyers C. Genetic Analysis of cis Regulatory Elements within the 5’ Region of the Human Papillomavirus Type 31 Upstream Regulatory Region during Different Stages of the Viral Life Cycle. JOURNAL OF VIROLOGY; 76(10): 4798–4809 (2002)
32. Kyo S, Tam A, Laimonnis A. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factor. VIROLOGY; 211: 184-197 (1995)
|